Ooof...I think the exhaustion I was warned about is taking me out a bit.
But that Aquapass for the GA aquarium was too tempting not to use whilst I'm 10 minutes away walking so I went one more time to do some writing.
Love that whale shark. Rock on Yushan, love you bud.
But that Aquapass for the GA aquarium was too tempting not to use whilst I'm 10 minutes away walking so I went one more time to do some writing.
Love that whale shark. Rock on Yushan, love you bud.
May 11, 2026 at 5:21 PM
Ooof...I think the exhaustion I was warned about is taking me out a bit.
But that Aquapass for the GA aquarium was too tempting not to use whilst I'm 10 minutes away walking so I went one more time to do some writing.
Love that whale shark. Rock on Yushan, love you bud.
But that Aquapass for the GA aquarium was too tempting not to use whilst I'm 10 minutes away walking so I went one more time to do some writing.
Love that whale shark. Rock on Yushan, love you bud.
Been working on #FaryRiverRailway on and off this month, but I've found some time recently to make the Aquapass - a smartcard designed as a nod to the TfL Oyster smartcard.
The Aquapass is part of an upcoming FRR update releasing as vALPHA 0.4.21!
#Roblox #RobloxStudio #RobloxDev
The Aquapass is part of an upcoming FRR update releasing as vALPHA 0.4.21!
#Roblox #RobloxStudio #RobloxDev
January 30, 2025 at 4:06 PM
Been working on #FaryRiverRailway on and off this month, but I've found some time recently to make the Aquapass - a smartcard designed as a nod to the TfL Oyster smartcard.
The Aquapass is part of an upcoming FRR update releasing as vALPHA 0.4.21!
#Roblox #RobloxStudio #RobloxDev
The Aquapass is part of an upcoming FRR update releasing as vALPHA 0.4.21!
#Roblox #RobloxStudio #RobloxDev
Aquapass’s fluid overload therapy system gains marketing approval in Israel www.medicaldevice-network.com/news/aquapas...
Aquapass’s fluid overload therapy system gains marketing approval in Israel
Aquapass has secured marketing approval in Israel for the AQUAPASS System, intended for patients experiencing fluid overload.
www.medicaldevice-network.com
December 9, 2025 at 5:21 PM
Aquapass’s fluid overload therapy system gains marketing approval in Israel www.medicaldevice-network.com/news/aquapas...
Congratulations Dr. Liviu Klein & #UCSFCardiology team members on enrolling the first UCSF patient into the REFORM-HF clinical trial. The study is testing a new technology called AQUAPASS, a wearable suit that helps remove excess fluids from heart failure patients. clinicaltrials.gov/study/NCT063...
July 31, 2026 at 8:53 PM
Congratulations Dr. Liviu Klein & #UCSFCardiology team members on enrolling the first UCSF patient into the REFORM-HF clinical trial. The study is testing a new technology called AQUAPASS, a wearable suit that helps remove excess fluids from heart failure patients. clinicaltrials.gov/study/NCT063...
AQUAPASS Completes Pivotal Trial Enrollment for ECCON System cgxpwire.com/aquapass-com...
AQUAPASS Completes Pivotal Trial Enrollment for ECCON System - cGxP.wire
Newton, Massachusetts, USA & Shefayim, Israel, August 10, 2026 AQUAPASS, Inc. has announced the completion of enrollment in its FDA pivotal REFORM-HF clinical trial, marking an important milestone in ...
cgxpwire.com
September 9, 2026 at 7:24 PM
AQUAPASS Completes Pivotal Trial Enrollment for ECCON System cgxpwire.com/aquapass-com...
AQUAPASS Completes Enrollment in Pivotal Heart Failure Trial of ECCON System bostonlifesciencestimes.com/2026/08/aqua...
AQUAPASS Completes Enrollment in Pivotal Heart Failure Trial of ECCON System - Boston Life Sciences Times
Newton, Mass. — AQUAPASS has completed enrollment in its pivotal REFORM-HF clinical trial evaluating the company’s ECCON System for removing excess fluid in patients with acute heart failure, marking ...
bostonlifesciencestimes.com
September 3, 2026 at 1:31 PM
AQUAPASS Completes Enrollment in Pivotal Heart Failure Trial of ECCON System bostonlifesciencestimes.com/2026/08/aqua...
REFORM-HF Pivotal Trial of Aquapass Eccon System for Fluid Overload Management Completes Enrollment on citoday.com/news/reform-...
REFORM-HF Pivotal Trial of Aquapass Eccon System for Fluid Overload Management Completes Enrollment - Cardiac Interventions Today
August 10, 2026—Aquapass, developer of a noninvasive, kidney-independent therapy for fluid overload management in patients experiencing heart fa
citoday.com
August 26, 2026 at 1:47 PM
REFORM-HF Pivotal Trial of Aquapass Eccon System for Fluid Overload Management Completes Enrollment on citoday.com/news/reform-...
AQUAPASS Completes Enrollment in REFORM-HF Pivotal Trial, Results to Be Presented at Major Heart Failure Conference This Fall www.biospace.com/press-releas...
AQUAPASS Completes Enrollment in REFORM-HF Pivotal Trial, Results to Be Presented at Major Heart Failure Conference This Fall
www.biospace.com
August 25, 2026 at 1:38 PM
AQUAPASS Completes Enrollment in REFORM-HF Pivotal Trial, Results to Be Presented at Major Heart Failure Conference This Fall www.biospace.com/press-releas...
AQUAPASS Nears Finish Line with Novel Fluid Overload Wearable briefglance.com/articles/aqu...
AQUAPASS Nears Finish Line with Novel Fluid Overload Wearable - BriefGlance.com
With its pivotal trial fully enrolled, AQUAPASS's skin-based therapy could soon offer a kidney-independent alternative to millions with heart failure.
briefglance.com
August 13, 2026 at 5:32 PM
AQUAPASS Nears Finish Line with Novel Fluid Overload Wearable briefglance.com/articles/aqu...
AQUAPASS Achieves Major Enrollment Milestone in REFORM-HF Trial for Heart Failure Management#United_States#Newton#Heart_Failure#AQUAPASS#ECCON_System
AQUAPASS Achieves Major Enrollment Milestone in REFORM-HF Trial for Heart Failure Management
AQUAPASS has successfully completed patient enrollment in the REFORM-HF pivotal trial, aimed at providing innovative solutions for fluid overload in heart failure patients. Results will be revealed at an upcoming heart failure conference.
third-news.com
August 10, 2026 at 1:51 PM
AQUAPASS Achieves Major Enrollment Milestone in REFORM-HF Trial for Heart Failure Management#United_States#Newton#Heart_Failure#AQUAPASS#ECCON_System
AQUAPASS Secures Marketing Approval in Israel for New Fluid Management Therapy#Israel#Fluid_Management#AQUAPASS#Shefayim
AQUAPASS Secures Marketing Approval in Israel for New Fluid Management Therapy
AQUAPASS has received marketing approval in Israel, allowing patients with fluid overload access to a groundbreaking non-invasive therapy that enhances their treatment options.
third-news.com
December 8, 2025 at 3:44 PM
AQUAPASS Secures Marketing Approval in Israel for New Fluid Management Therapy#Israel#Fluid_Management#AQUAPASS#Shefayim
Clinical trial aims to reduce fluid overload for congestive heart failure patients spectrumlocalnews.com/nys/hudson-v...
Clinical trial reducing fluid overload for congestive heart failure patients
Rochester General Hospital is the first site in the U.S. for the AquaPass clinical trial.
spectrumlocalnews.com
March 16, 2026 at 1:08 PM
Clinical trial aims to reduce fluid overload for congestive heart failure patients spectrumlocalnews.com/nys/hudson-v...
Aquapass System Approved in Israel for Fluid Overload Treatment citoday.com/news/aquapas...
Aquapass System Approved in Israel for Fluid Overload Treatment - Cardiac Interventions Today
December 12, 2025—Aquapass, developer of noninvasive, kidney-independent solutions for fluid overload management in patients experiencing heart
citoday.com
December 15, 2025 at 2:12 PM
Aquapass System Approved in Israel for Fluid Overload Treatment citoday.com/news/aquapas...
